Publications:  Dr Michael Hornsey

WAREHAM DW(2018). Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii. Scientific Reports

Betts JW, Hornsey M, Wareham DW, La Ragione RM(2017). In vitro and In vivo Activity of Theaflavin-Epicatechin Combinations versus Multidrug-Resistant Acinetobacter baumannii. Infect Dis Ther

Niebel M, Quick J, Prieto AMG, Hill RLR, Pike R, Huber D, David M, Hornsey M et al.(2015). Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. Int J Antimicrob Agents vol. 46, (5) 572-575.

Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW(2014). In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother vol. 58, (6) 3541-3546.

Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW(2013). Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. Journal of Medical Microbiology vol. 62, (PART 12) 1823-1827.

Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham DW(2013). Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J Med Microbiol vol. 62, (Pt 12) 1823-1827.

Phee L, Hornsey M, Wareham DW(2013). In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. European Journal of Clinical Microbiology and Infectious Diseases vol. 32, (10) 1291-1294.

Phee L, Hornsey M, Wareham DW(2013). In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. Eur J Clin Microbiol Infect Dis vol. 32, (10) 1291-1294.

Hornsey M, Phee L, Stubbings W, Wareham DW(2013). In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. International Journal of Antimicrobial Agents vol. 42, (4) 343-346.

Hornsey M, Phee L, Stubbings W, Wareham DW(2013). In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens. Int J Antimicrob Agents vol. 42, (4) 343-346.

Wareham D, Phee L, Hornsey M (2013). Isolation and characterisation of a novel Nesterenkonia species from a human bloodstreaminfection. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. vol. 42, S141-S142.

Veleba M, De Majumdar S, Hornsey M, Woodford N, Schneiders T(2013). Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Antimicrob Chemother vol. 68, (5) 1011-1018.

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW(2013). Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. Journal of Clinical Pathology vol. 66, (4) 348-350.

Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW(2013). Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. J Clin Pathol vol. 66, (4) 348-350.

Hornsey M, Phee L, Longshaw C, Wareham DW(2013). In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. International Journal of Antimicrobial Agents vol. 41, (3) 285-287.

Hornsey M, Phee L, Longshaw C, Wareham DW(2013). In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. Int J Antimicrob Agents vol. 41, (3) 285-287.

Hornsey M, Longshaw C, Phee L, Wareham DW(2012). In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens. Antimicrob Agents Chemother vol. 56, (6) 3080-3085.

Hornsey M, Phee L, Wareham DW(2011). A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother vol. 55, (12) 5952-5954.

Hornsey M, Wareham DW(2011). In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob Agents Chemother vol. 55, (7) 3534-3537.

Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H et al.(2011). Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother vol. 55, (7) 3370-3379.

Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T et al.(2011). Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother vol. 66, (7) 1499-1503.

Wareham DW, Gordon NC, Hornsey M(2011). In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J Antimicrob Chemother vol. 66, (5) 1047-1051.

Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K et al.(2010). AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother vol. 65, (8) 1589-1593.

Hornsey M, Ellington MJ, Doumith M, Scott G, Livermore DM, Woodford N(2010). Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. Int J Antimicrob Agents vol. 35, (5) 478-481.

Hornsey M, Ellington MJ, Doumith M, Hudson S, Livermore DM, Woodford N(2010). Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome. J Antimicrob Chemother vol. 65, (3) 479-482.